Delivery Order SPE2D020D0020-SPE2D025F0592
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order to Anbex Inc. on August 1, 2025, for the procurement of IOSAT 130 mg potassium iodide tablets in 14-tablet packages. This $4,455 firm fixed-price delivery order, which must be completed by August 4, 2025, was awarded without set-aside designations, allowing Anbex to compete openly in the federal marketplace. The product will be delivered to St. George, Utah, where Anbex maintains its primary operations and...
- This federal contract award, valued at $100,000.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Anbex Inc., a for-profit Subchapter S Corporation based in Utah and Virginia. The contract is for the delivery of 130mg potassium iodide tablets, packaged in 14-tablet quantities, which are critical medical countermeasures used to protect the thyroid gland during radiation emergencies. This contract does not have a set-aside designation, indicating Anbex competed openly...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Anbex Inc., a for-profit Subchapter S Corporation based in Utah and Virginia. The $224,707.50 firm-fixed-price delivery order is for the "MANUFACTURE/DISTRIB" of pharmaceutical products, specifically 130mg potassium iodide tablets packaged in 14-tablet quantities. The contract has no set-aside designation, indicating Anbex competed openly for this award. Anbex holds a larger Indefinite...
- Anbex Inc. has been awarded a $1,500 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 130mg potassium iodide tablets in 14 tablet packages. The delivery order was issued on November 3, 2023 with a completion date of November 8, 2023 and performance will occur at Anbex's location in St. George, Utah. No set-aside provisions were applied to this delivery order placed against Anbex's indefinite-delivery/indefinite-quantity contract with the DLA...
- Anbex Inc. has been awarded a $4,500 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 14,130 milligram potassium iodide tablets. The Defense Logistics Agency will utilize this product delivery from Anbex's facility in St. George, Utah to support its medical supply needs between August 16-21, 2023. No subcontractors or set aside designations were specified. This delivery order falls under the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Anbex Inc., a manufacturer and distributor of potassium iodide tablets and other pharmaceutical products. The $249,825.00 delivery order is for "Other Medical" products and services, with a firm fixed price and performance occurring at Anbex's facilities in Utah and Virginia. No set-aside designation was used. This award is part of Anbex's larger indefinite-delivery/indefinite-quantity...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Anbex Inc., a for-profit Subchapter S Corporation based in St. George, Utah. The $4,050.00 Firm Fixed Price Delivery Order is for the provision of 14-tablet packages of IOSAT 130 MG TABLET, a critical medical countermeasure used to protect the thyroid gland during radiation emergencies. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract...
- Anbex Inc. has been awarded a $3,750 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 4561849626 potassium iodide tablets. The 130 mg tablets will be delivered in quantities of 14 tablets per package to a location in St. George, Utah by August 22, 2023 under the firm fixed price contract. No set-aside designation or subcontractors were identified. The Defense Logistics Agency Troop Support Medical contract...
- This federal contract award is for the delivery of IOSAT 130 MG TABLET 14S, a type of potassium iodide tablet, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,050.00, was awarded to Anbex Inc., a for-profit Subchapter S Corporation that specializes in manufacturing and distributing pharmaceutical products, particularly potassium iodide tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract valued at one hundred fifteen dollars to Anbex Inc. of Williamsburg, Virginia. The contract is for the delivery of four hundred fifty-five potassium iodide tablets, each containing one hundred thirty milligrams of active pharmaceutical ingredient, to support the agency's medical countermeasures programs. No set-aside provisions were applied to this procurement. Anbex will deliver the specified...
- SPE2D020D0020Indefinite Delivery Contract
- SPE2D020D0020-SPE2D025F0592Delivery Order
Anbex Inc., a St. George, Utah-based pharmaceutical manufacturer specializing in potassium iodide medical countermeasures, was awarded a delivery order valued at $335,028.39 on September 12, 2025, for other medical supplies. The contract, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by October 26, 2026, and will be performed at the company's Utah location. The award is funded by the Medical Supply Chain division within the Department of Defense, reflecting the government's ongoing demand for pharmaceutical products and emergency preparedness materials. This delivery order operates under Anbex's larger indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $3.5 billion through September 2030. Anbex has demonstrated consistent performance as a federal supplier since its SAM.gov registration in 2002, with a primary focus on providing potassium iodide tablets—particularly the IOSAT 130 mg formulation—which serve as critical medical countermeasures for thyroid protection during radiation emergencies. The company's contract history includes work with multiple federal agencies including the Department of Homeland Security and Department of State, positioning it as an established supplier within the federal medical supply chain and national defense readiness framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $335.0k | 9/12/25 |